Medexus Pharmaceuticals Inc (TSE:MDP) has released an update.
Medexus Pharmaceuticals Inc has announced a conference call for June 26, 2024, to discuss its fourth fiscal quarter and full fiscal year performance, with the financial statements to be released post-market on June 25. The call will attract investors from Canada, the U.S., and internationally, with live and replay options available via webcast and phone. Medexus, known for its focus on rare disease treatments and specialty pharmaceuticals, runs a strong North American commercial platform.
For further insights into TSE:MDP stock, check out TipRanks’ Stock Analysis page.
